KYinno Biotechnology Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
130
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$34.5M
- Investors
-
9
KYinno Biotechnology General Information
Description
Developer of oncology drugs intended to accelerate cancer drug discovery and development. The company offers immune treatments against cancer, antibody discovery workflows, engineered cellular systems, and next-generation kinase inhibitor design, dedicated to oncology drug discovery and customized product development, enabling these groups to progress their scientific programs effectively.
Contact Information
Website
www.kyinno.comCorporate Office
- F2 Building, Yizhuang Biomedical Park
- Number 88 Kechuang Six Street, Yizhuang Economic and Technological Development East Zone
- Beijing, 101111
- China
Corporate Office
- F2 Building, Yizhuang Biomedical Park
- Number 88 Kechuang Six Street, Yizhuang Economic and Technological Development East Zone
- Beijing, 101111
- China
KYinno Biotechnology Timeline
KYinno Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 24-Feb-2025 | $34.5M | Completed | Generating Revenue | ||
| 4. Secondary Transaction - Private | 03-Jan-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A1) | 24-Oct-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 29-Jan-2021 | $7.86M | $9M | Completed | Generating Revenue | |
| 1. Early Stage VC | 10-Jul-2017 | $1.18M | $1.18M | Completed | Startup |
KYinno Biotechnology Comparisons
Industry
Financing
Details
KYinno Biotechnology Competitors (1)
One of KYinno Biotechnology’s competitors is Horizon Discovery, a Formerly VC-backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Horizon Discovery | Formerly VC-backed | Cambridge, United Kingdom |
KYinno Biotechnology Patents
KYinno Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026145542-A1 | Polypeptide and antibody containing same | Pending | 30-Dec-2024 | ||
| AU-2025239846-A1 | Polypeptide and use thereof in construction of bispecific antibody containing common light chain | Pending | 22-Mar-2024 | ||
| JP-2026505866-A | Polypeptide acting as a light chain and antibody containing the same | Pending | 15-Feb-2023 | ||
| AU-2024221409-A1 | Polypeptide and antibody containing same acting as light-chain | Pending | 15-Feb-2023 | ||
| EP-4667489-A1 | Polypeptide and antibody containing same acting as light-chain | Pending | 15-Feb-2023 | C07K16/2803 |
KYinno Biotechnology Signals
KYinno Biotechnology Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing State-owned Capital Operation and Management | Government | Minority | ||
| BioTrack Capital | Venture Capital | Minority | ||
| China Everbright | Asset Manager | Minority | ||
| Renai Capital | Corporate Venture Capital | Minority | ||
| Yizhuang Guotou | Venture Capital | Minority |
KYinno Biotechnology FAQs
-
When was KYinno Biotechnology founded?
KYinno Biotechnology was founded in 2017.
-
Where is KYinno Biotechnology headquartered?
KYinno Biotechnology is headquartered in Beijing, China.
-
What is the size of KYinno Biotechnology?
KYinno Biotechnology has 130 total employees.
-
What industry is KYinno Biotechnology in?
KYinno Biotechnology’s primary industry is Drug Discovery.
-
Is KYinno Biotechnology a private or public company?
KYinno Biotechnology is a Private company.
-
What is KYinno Biotechnology’s current revenue?
The current revenue for KYinno Biotechnology is .
-
How much funding has KYinno Biotechnology raised over time?
KYinno Biotechnology has raised $59M.
-
Who are KYinno Biotechnology’s investors?
Beijing State-owned Capital Operation and Management, BioTrack Capital, China Everbright, Renai Capital, and Yizhuang Guotou are 5 of 9 investors who have invested in KYinno Biotechnology.
-
Who are KYinno Biotechnology’s competitors?
Horizon Discovery is a competitor of KYinno Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process